Search

Search Constraints

You searched for: Author/Creator Da Costa, Daniel

Search Results

1. Corrigendum to "Synthesis of unnatural 2- and 3-deoxyfuranose analogues" [Tetrahedron Lett. 55 (2014) 3706–3708]. Issue 15 (8th April 2015)

2. Corrigendum to "Synthesis of unnatural 3′-phospha-2′-deoxyfuranose nucleoside analogues" [Tetrahedron Lett. 55 (2014) 6328–6330]. Issue 15 (8th April 2015)

3. CTNI-68. FIREFLY-1 (PNOC026): PHASE 2 STUDY OF PAN-RAF INHIBITOR TOVORAFENIB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RAF-ALTERED RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMA OR ADVANCED SOLID TUMORS. (14th November 2022)

4. Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor. Issue 11 (1st June 2017)

5. Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer. Issue 2 (19th December 2020)

7. Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase. Issue 18 (15th September 2016)

8. Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase. Issue 18 (15th September 2016)

9. The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2′-α-chloro-2′-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors. Issue 18 (15th September 2017)